+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "ACE Inhibitor"

Anti-Hypertensive Drugs - Global Strategic Business Report - Product Thumbnail Image

Anti-Hypertensive Drugs - Global Strategic Business Report

  • Report
  • July 2026
  • 293 Pages
  • Global
From
From
From
From
Angina Market Report 2026 - Product Thumbnail Image

Angina Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
From
From
From
From
From
From
Heart Failure Epidemiology Forecast 2026-2035 - Product Thumbnail Image

Heart Failure Epidemiology Forecast 2026-2035

  • Report
  • May 2026
  • 150 Pages
  • Global
From
Hypertension Drug Pipeline Analysis Report 2026 - Product Thumbnail Image

Hypertension Drug Pipeline Analysis Report 2026

  • Drug Pipelines
  • May 2026
  • 150 Pages
  • Global
From
From
From
From
Loading Indicator

The ACE Inhibitor market is a segment of the pharmaceutical industry that focuses on drugs used to treat high blood pressure, heart failure, and other cardiovascular diseases. ACE inhibitors are a type of medication that works by blocking the action of an enzyme called angiotensin-converting enzyme (ACE). This enzyme is responsible for producing a hormone called angiotensin II, which can cause blood vessels to narrow and increase blood pressure. By blocking the action of ACE, ACE inhibitors can help reduce blood pressure and improve the symptoms of heart failure. ACE inhibitors are typically prescribed in combination with other medications, such as diuretics, beta-blockers, and calcium channel blockers. They are also used to treat other conditions, such as kidney disease, diabetes, and migraines. Some companies in the ACE Inhibitor market include Pfizer, Merck, Novartis, Sanofi, and AstraZeneca. Show Less Read more